We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

KIT rs121913235: Understanding This Rare Genetic Variant

rs121913235
Health Predisposition
Moderate evidenceGene: KIT

The rs121913235 variant is a rare genetic change located in the KIT gene. It is primarily studied in the context of gastrointestinal stromal tumors (GIST) and its potential influence on how these tumors respond to targeted therapies like imatinib.

What each genotype means

G/GLower attention

Typical KIT gene profile

This genotype represents the common, expected sequence for the KIT gene in the general population. It does not carry the specific mutation associated with gastrointestinal stromal tumors (GIST) or altered sensitivity to imatinib therapy. No specific clinical action is indicated based on this result.

This is the most common genotype found in the vast majority of the human population.

G/CHigher attention

KIT variant carrier

This genotype indicates the presence of a rare, likely pathogenic missense variant in the KIT gene. Research associates this specific change with an increased risk for gastrointestinal stromal tumors (GIST) and potential sensitivity to imatinib therapy. Please discuss these findings with your clinician or a genetic counselor to understand your personal health context and any appropriate screening or management steps.

This genotype is extremely rare and is not typically found in the general population.

What is the rs121913235 Variant?

The rs121913235 variant is a specific change in the DNA sequence of the KIT gene. In genetics, a variant like this is often referred to as a missense mutation, meaning it results in a change to the amino acid sequence of the protein the gene produces. This variant is located within the KIT gene, which provides instructions for making a protein called a receptor tyrosine kinase. These proteins act as chemical switches that help regulate cell growth, division, and survival. When a variant occurs in this gene, it can potentially alter the function of the KIT protein, leading to abnormal signaling within cells. Because this variant is rare, it is not typically found in the general population and is most often identified during clinical investigations of specific tumor types.

The Role of the KIT Gene

The KIT gene is essential for the development and function of various cell types, including those in the digestive system. It encodes the KIT protein, which sits on the surface of cells and receives signals that tell the cell to grow or divide. In healthy tissues, this process is tightly controlled. However, in certain conditions like gastrointestinal stromal tumors (GIST), the KIT gene can acquire mutations that cause the protein to become 'constitutively activated.' This means the switch is stuck in the 'on' position, causing cells to multiply uncontrollably. Understanding the specific location and nature of these mutations is a major focus of oncology research, as different mutations can change how a tumor behaves and how it responds to medical treatments.

Research and Clinical Associations

Research has established a strong link between KIT mutations and the development of GIST. Studies have shown that the majority of GIST cases harbor mutations in the KIT gene, which serve as key drivers of tumor growth. The rs121913235 variant is categorized as a health predisposition variant because of its association with these tumors. Furthermore, the specific mutational status of a tumor is often used by clinicians to predict how well a patient might respond to targeted therapies, such as imatinib. Imatinib is a tyrosine kinase inhibitor designed to block the activity of the KIT protein. While many KIT mutations are sensitive to this drug, some variants may influence the level of sensitivity or contribute to the development of drug resistance over time. Evidence for these associations is considered moderate, as clinical outcomes can vary significantly between individuals.

What You Can and Cannot Do With This Information

Genetic information regarding variants like rs121913235 is intended for educational purposes and should not be used for self-diagnosis or to make medical decisions. If you have concerns about your genetic health or a family history of GIST, it is essential to consult with a healthcare professional, such as a genetic counselor or an oncologist. They can provide context based on your personal medical history and guide you through appropriate testing or screening. If you are currently undergoing treatment or have been prescribed medications like imatinib, always discuss your genetic profile and any questions about drug response or dosing directly with your clinician or pharmacist. They are the only ones qualified to interpret how specific genetic findings apply to your unique clinical situation.

How common is this variant?

The rs121913235 variant is classified as rare in the general population, meaning it is not commonly found in large-scale genomic databases.

Frequently asked questions

Is rs121913235 a cause of cancer?

The variant is associated with gastrointestinal stromal tumors (GIST), but it is not a direct cause of cancer in the way that a virus or environmental toxin might be. It is a genetic factor that may predispose an individual to tumor development or influence how a tumor behaves.

Does having this variant mean I will develop a tumor?

No, having a genetic variant does not guarantee that you will develop a tumor. Many factors, including other genetic influences and environmental exposures, contribute to the development of health conditions.

Can I get tested for this variant?

Clinical genetic testing is typically performed when there is a specific medical reason, such as a diagnosis of GIST. You should speak with your doctor if you believe genetic testing is relevant to your health.

How does this variant affect imatinib treatment?

The variant may influence how a tumor responds to imatinib, a targeted therapy. Clinical studies use this information to help predict the effectiveness of the drug, but you must discuss your specific treatment plan with your oncologist.

Sources & further reading

Educational information only, last refreshed 10/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs121913235?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29

Related variants in KIT